Sally Lord

Dr Sally Lord is a Senior Research Fellow at the NHMRC Clinical Trials Centre, University of Sydney's Sydney Medical School. Her research focuses on epidemiology, clinical trial design, biomarker development, and evidence-based medicine. She specializes in evaluating diagnostic tests, clinical trial methodologies, and cancer outcomes. Dr Lord collaborates extensively on studies involving breast, ovarian, and lung cancers, with a focus on metastasis detection, treatment efficacy, and patient survival analysis.

Her work includes population-based health record linkage studies and systematic reviews to assess clinical practices. She has contributed to guidelines for diagnostic test evaluation and clinical trial design, emphasizing patient-centered outcomes and healthcare policy. Dr Lord’s research also addresses challenges in oncology, such as biomarker validation, therapeutic response prediction, and cost-effectiveness of imaging strategies.

Publications highlight her expertise in cancer epidemiology, clinical trial methodologies, and translational research. She is a key contributor to international collaborations, including studies on ovarian cancer maintenance therapy, metastatic breast cancer survival trends, and biomarker-driven treatment strategies.